Detalhe da pesquisa
1.
A phase 2a, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral gonadotropin-releasing hormone antagonist, ASP1707, in postmenopausal female patients with rheumatoid arthritis taking methotrexate.
Mod Rheumatol
; 31(1): 53-60, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-32075475
2.
A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma.
Invest New Drugs
; 38(4): 1056-1066, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31444589
3.
Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3).
Ann Rheum Dis
; 78(10): 1320-1332, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31350270
4.
Efficacy and safety of 3-month dosing regimen of degarelix in Japanese subjects with prostate cancer: A phase III study.
Cancer Sci
; 109(6): 1920-1929, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29624800
5.
Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations.
Cancer Sci
; 109(9): 2852-2862, 2018 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-29972716
6.
Efficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding study.
Jpn J Clin Oncol
; 47(5): 438-446, 2017 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28334771
7.
[Survey of statistical analysis in Journal of Pharmacological Sciences: typical inappropriate uses and countermeasures against them].
Nihon Yakurigaku Zasshi
; 133(6): 306-10, 2009 Jun.
Artigo
Japonês
| MEDLINE | ID: mdl-19521026
8.
[Statistical selection of an appropriate enzyme-inhibition model].
Nihon Yakurigaku Zasshi
; 133(6): 313-8, 2009 Jun.
Artigo
Japonês
| MEDLINE | ID: mdl-19521027